Ars Pharmaceutica

Scope & Guideline

Exploring the depths of pharmacology and toxicology.

Introduction

Explore the comprehensive scope of Ars Pharmaceutica through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Ars Pharmaceutica in depth and align your research initiatives with current academic trends.
LanguageMulti-Language
ISSN0004-2927
PublisherUNIV GRANADA, EDITORIAL
Support Open AccessNo
Country-
TypeJournal
Convergefrom 1980 to 1981, from 1983 to 1984, from 1986 to 2001, from 2003 to 2017 (coverage discontinued in Scopus)
AbbreviationARS PHARM / Ars Pharm.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressANTIGUO COLEGIO MAXIMO, CAMPUS DE CARTUJA, GRANADA 18071, SPAIN

Aims and Scopes

Ars Pharmaceutica is dedicated to advancing the field of pharmaceutical sciences through rigorous research and analysis. The journal encompasses a diverse range of topics relevant to pharmacology, drug development, clinical pharmacy, and health care practices, reflecting its commitment to improving patient care and public health.
  1. Pharmacological Research and Drug Development:
    The journal prioritizes studies related to the discovery, development, and optimization of pharmaceutical compounds, including bioavailability, pharmacokinetics, and therapeutic efficacy.
  2. Clinical Pharmacy and Therapeutics:
    A significant focus on clinical applications of pharmacy, including medication management, adherence, and the role of pharmacists in patient care.
  3. Public Health and Drug Safety:
    Research addressing drug-related problems, medication safety, and public health implications, including the evaluation of drug use patterns and adverse effects.
  4. Analytical and Methodological Advances:
    Innovations in analytical techniques for drug quantification and characterization, alongside the development of new methodologies for pharmaceutical research.
  5. Ethnopharmacology and Natural Products:
    Investigation of traditional medicine and natural compounds, assessing their pharmacological properties and potential therapeutic applications.
The journal has demonstrated a dynamic evolution in its focus, reflecting contemporary challenges and interests in the pharmaceutical sciences. Recent publications indicate several emerging themes that are gaining traction among researchers.
  1. Digital Health and Technology in Pharmacy:
    An increasing number of studies explore the integration of digital tools and technologies in pharmacy practice, including telepharmacy and data analytics for improving patient outcomes.
  2. Patient-Centric Research:
    Research emphasizing patient engagement, adherence to therapy, and the role of pharmacists in community settings is on the rise, highlighting the importance of patient perspectives in pharmaceutical care.
  3. Pharmacogenomics and Personalized Medicine:
    Emerging research on the genetic basis of drug response is gaining attention, with implications for tailoring therapies to individual patients based on their genetic profiles.
  4. Impact of Pandemics on Drug Use and Patient Care:
    The COVID-19 pandemic has spurred a significant increase in studies evaluating drug use patterns, vaccine safety, and the role of pharmacists in managing public health crises.
  5. Sustainable Pharmaceutical Practices:
    There is a growing trend towards research focusing on sustainability in pharmaceutical manufacturing and drug delivery systems, reflecting global concerns about environmental impact.

Declining or Waning

While Ars Pharmaceutica continues to expand its research horizons, certain themes have shown a decline in frequency or interest. This shift may reflect evolving priorities within the field or changing research landscapes.
  1. Traditional Medicinal Practices:
    Research focusing on traditional herbal medicines and their applications has seen a reduction, possibly due to an increasing emphasis on evidence-based and clinical research.
  2. Pharmaceutical Marketing and Regulations:
    Themes related to the marketing authorization of drugs and regulatory affairs have become less prominent, suggesting a shift towards more practical clinical applications and patient-centered research.
  3. Single Disease Focus Studies:
    Studies addressing specific diseases without broader implications or interdisciplinary approaches have decreased, indicating a trend towards more integrated and holistic health research.
  4. Historical Perspectives in Pharmacy:
    Papers exploring historical aspects of pharmaceutical practices and education have waned, as current research trends lean towards contemporary issues and advancements.

Similar Journals

Acta Pharmaceutica Sinica B

Bridging Knowledge and Innovation in Pharmaceutics
Publisher: INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCESISSN: 2211-3835Frequency: 6 issues/year

Acta Pharmaceutica Sinica B is a prestigious open access journal that has been setting the standard in the field of pharmacology, toxicology, and pharmaceutics since its establishment in 2011. Published by the Institute of Materia Medica, Chinese Academy of Medical Sciences, the journal serves as a vital platform for researchers, professionals, and students seeking to disseminate innovative findings in drug development, pharmaceutical sciences, and therapeutic applications. With an impressive impact factor reflecting its high academic quality, Acta Pharmaceutica Sinica B has achieved Q1 status in the category of Pharmacology, Toxicology and Pharmaceutics as of 2023, ranking #1 out of 80 journals in General Pharmacology. This journal not only focuses on the latest advancements in drug research and formulation but also emphasizes interdisciplinary approaches, fostering collaborations that span various scientific domains. The accessible nature of the journal, combined with its rigorous peer-review process, ensures that crucial insights and breakthroughs reach a global audience swiftly and effectively. For those looking to stay at the forefront of pharmaceutical research, Acta Pharmaceutica Sinica B is an indispensable resource.

PHARMACIA

Elevating research in pharmaceutical sciences to global heights.
Publisher: PENSOFT PUBLISHERSISSN: 0428-0296Frequency: 4 issues/year

PHARMACIA is a distinguished open-access journal, published by PENSOFT PUBLISHERS, that has been a pivotal platform for advancing the field of pharmaceutical sciences since 2007. This journal, with ISSN 0428-0296 and E-ISSN 2603-557X, is based in Bulgaria and continues to publish high-quality research and reviews relevant to pharmacy, pharmacology, and toxicology. Recognized in the Q3 category for Pharmaceutical Sciences and Pharmacology (medical), as well as Q2 in Pharmacy according to the latest rankings, PHARMACIA is celebrated for its commitment to fostering knowledge dissemination and innovation in drug development, therapeutic approaches, and pharmacological research. With a Scopus rank of #17 in Pharmacy and recognition in various health professions, the journal attracts contributions from researchers, professionals, and students seeking to impact the pharmaceutical landscape. Its convenient open-access format ensures that articles are readily available to a global audience, encouraging collaboration and advancement in the life sciences.

Istanbul Journal of Pharmacy

Fostering collaboration in the world of pharmacy.
Publisher: ISTANBUL UNIV, FAC PHARMACYISSN: Frequency: 3 issues/year

Istanbul Journal of Pharmacy, published by Istanbul University, Faculty of Pharmacy, is a pivotal platform dedicated to the advancement of pharmaceutical sciences and technology. This journal serves as a vital resource for researchers, professionals, and students alike, seeking to disseminate cutting-edge research, reviews, and innovative methodologies within the pharmaceutical discipline. With a commitment to open access, the journal aims to foster a collaborative environment that promotes information sharing and scholarly discourse. The Istanbul Journal of Pharmacy invites submissions that delve into diverse topics ranging from drug formulation to pharmacokinetics, ensuring that readers are equipped with the latest insights and discoveries in the field. This journal is positioned to enhance scientific communication within the pharmaceutical community and support the continuous evolution of pharmacy practice and education globally.

BIOLOGICAL & PHARMACEUTICAL BULLETIN

Unlocking New Horizons in Pharmaceutical Research
Publisher: PHARMACEUTICAL SOC JAPANISSN: 0918-6158Frequency: 12 issues/year

BIOLOGICAL & PHARMACEUTICAL BULLETIN, published by the PHARMACEUTICAL SOC JAPAN, is a prominent peer-reviewed journal that serves the fields of medicine, pharmaceutical science, and pharmacology. With an ISSN of 0918-6158 and an E-ISSN of 1347-5215, this publication has been crucial in disseminating innovative research since its inception in 1993, and it continues to contribute significantly to the body of knowledge as it converges towards 2024. Despite being classified as a non-open access journal, it maintains a respectable Q3 ranking in Medicine (miscellaneous) and Q2 in Pharmaceutical Science, highlighting its critical role in advancing scientific discourse in these areas. With Scopus rankings placing it in the 51st percentile for Pharmaceutical Science and 38th percentile for Pharmacology, BIOLOGICAL & PHARMACEUTICAL BULLETIN is an essential resource for researchers, professionals, and students looking to stay abreast of cutting-edge developments and trends in biomedicine and drug development.

Journal of Research in Pharmacy

Pioneering Insights in Pharmacological Research
Publisher: MARMARA UNIVISSN: 2630-6344Frequency: 4 issues/year

Journal of Research in Pharmacy, published by Marmara University, serves as a pivotal platform for the dissemination of innovative research in the field of pharmacology and pharmaceutical sciences. With an ISSN of 2630-6344 and an E-ISSN of the same, this journal is dedicated to publishing high-quality research spanning various aspects of pharmacology, toxicology, and pharmaceutics. The journal, categorized in Q3 for both pharmacology (medical) and miscellaneous pharmacology, toxicology, and pharmaceutics in 2023, showcases the ongoing evolution of these disciplines amid growing scientific inquiry. As of now, it ranks #56/80 in general pharmacology, toxicology and pharmaceutics, spotlighting its relevance within the academic community. Although it operates under a traditional access model, the journal is committed to providing researchers, professionals, and students with a comprehensive understanding of contemporary challenges and innovations in pharmacy research. Established in 2019, it continues to foster academic dialogue and contribute significantly to the advancement of pharmacological sciences until at least 2024. For all interested in cutting-edge pharmaceutical research, this journal presents an invaluable resource from its base in Istanbul, Turkey.

Annales Pharmaceutiques Francaises

Unveiling the Latest Breakthroughs in Pharmacology
Publisher: MASSON EDITEURISSN: 0003-4509Frequency: 6 issues/year

Annales Pharmaceutiques Francaises, an esteemed journal published by MASSON EDITEUR, serves as a pivotal platform in the field of Pharmaceutical Science and Pharmacology. Established in 1945 and continuing through 2024, this journal showcases significant contributions to the advancement of pharmaceutical sciences, bridging the gap between research, development, and practical applications. Although it currently does not offer open access, its established reputation and Q3 ranking in both Pharmaceutical Science and Pharmacology highlight its role in disseminating impactful studies. With an ISSN of 0003-4509, the journal is indexed in Scopus, boasting a respectable percentile ranking for both domains, and remains a vital resource for researchers, professionals, and students dedicated to exploring the latest advancements in the pharmaceutical field. Based in France, at 21 Street Camille Desmoulins, Issy, 92789 Moulinais Cedex 9, it aims to foster a deeper understanding of pharmacological innovations and therapeutic agents among its diverse readership.

JOURNAL OF PHARMACEUTICAL SCIENCES

Fostering collaboration for groundbreaking pharmaceutical discoveries.
Publisher: ELSEVIER SCIENCE INCISSN: 0022-3549Frequency: 12 issues/year

The JOURNAL OF PHARMACEUTICAL SCIENCES, published by ELSEVIER SCIENCE INC, stands as a cornerstone in the field of pharmaceutical sciences, offering a platform for innovative research and advancements since its inception in 1961. With an impressive Scopus Rank of #36 out of 183 in the Pharmaceutical Science category, this journal is recognized for its commitment to disseminating high-quality, peer-reviewed studies that significantly contribute to the realms of pharmacology, toxicology, and pharmaceutics. Holding a 2023 Q2 category quartile, it attracts a diverse readership encompassing researchers, industry professionals, and students eager to advance their understanding and expertise. While the journal is not open access, it ensures valuable insights in every issue, making it an essential resource for those dedicated to the evolving landscape of pharmaceutical research. With an impact factor that reflects its relevance and influence, the JOURNAL OF PHARMACEUTICAL SCIENCES continues to shape the discourse in its domain, fostering innovation and collaboration among scholars worldwide.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Empowering practitioners with innovative medication insights.
Publisher: WILEY-HINDAWIISSN: 0269-4727Frequency: 1 issue/year

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, an esteemed publication in the field of pharmacology, is published by Wiley-Hindawi and has been at the forefront of clinical research since its inception in 1976. Operating primarily from the United Kingdom, this journal features a diverse array of articles that encompass both fundamental and practical aspects of clinical pharmacy, thereby supporting the advancement of therapeutic practices. With an ISSN of 0269-4727 and an E-ISSN of 1365-2710, it is indexed in key databases and holds respectable ranks within its categories; achieving Q3 in Pharmacology and Q2 in Medical Pharmacology in the latest quartile rankings. Its Scopus ranking reflects both its quality and relevance, being positioned in the 55th percentile for medical pharmacology and the 45th for pharmacology, toxicology, and pharmaceutics. Although it does not currently operate under an Open Access model, the journal's extensive readership and rigorous peer-review process ensure that the latest research reaches practitioners and academics alike. With a commitment to bridging the gap between pharmacological science and clinical practice, the JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS remains a critical resource for professionals striving to enhance patient outcomes through informed medication management.

JOURNAL OF PHARMACY AND PHARMACOLOGY

Fostering collaboration in the realm of drug discovery.
Publisher: OXFORD UNIV PRESSISSN: 0022-3573Frequency: 12 issues/year

Journal of Pharmacy and Pharmacology, published by Oxford University Press, is a prestigious academic journal dedicated to the advancement of knowledge in the fields of pharmaceutical sciences and pharmacology. With a strong heritage dating back to 1949, this journal maintains a robust influence, as evidenced by its ranking in the second quartile (Q2) across both Pharmaceutical Science and Pharmacology categories for 2023. The journal is accessible without an open access option, ensuring traditional academic engagement and providing valuable insights for researchers and professionals. It boasts an impressive Scopus ranking, with a percentile positioning of 72nd in Pharmaceutical Science and 67th in Pharmacology. Aimed at fostering innovative research and facilitating the exchange of cutting-edge scientific knowledge, the Journal of Pharmacy and Pharmacology serves as an essential resource for scientists, students, and healthcare professionals committed to enhancing therapeutic outcomes and advancing pharmaceutical innovations.

Brazilian Journal of Pharmaceutical Sciences

Bridging Research and Practice in Pharmaceutical Sciences.
Publisher: UNIV SAO PAULO, CONJUNTO QUIMICASISSN: 1984-8250Frequency: 4 issues/year

The Brazilian Journal of Pharmaceutical Sciences is a prestigious and peer-reviewed journal dedicated to disseminating significant research across the fields of Pharmacology, Toxicology, and Pharmaceutics. Published by UNIV SAO PAULO, CONJUNTO QUIMICAS, this journal has been an Open Access platform since 2009, making it accessible to a global audience, fostering collaboration and knowledge sharing among researchers and professionals. With an ISSN of 1984-8250 and an E-ISSN of 2175-9790, it holds a respectable Q3 ranking in these fields for 2023, indicating its contribution to the scientific community's understanding and advancement of pharmaceutical sciences. As it converges from 2009 to 2024, the journal continues to address emerging trends and critical topics in drug development, safety, and efficacy, positioning itself as an essential resource for students, researchers, and practitioners seeking to contribute to and stay informed about advancements in pharmacological research. With its publication address in São Paulo, Brazil, the journal serves as a key outlet for Brazilian and international scholars alike.